SPECT myocardial perfusion imaging in liver transplantation candidates

The optimal cardiovascular evaluation prior to liver transplantation remains controversial and includes stress echocardiography, stress MPI, cardiac CTA, and coronary angiography. This study summarizes our experience of the past decade using SPECT MPI in patients with end-stage liver disease, includ...

Full description

Saved in:
Bibliographic Details
Published in:Journal of nuclear cardiology 2020-02, Vol.27 (1), p.254-265
Main Authors: Duvall, W. Lane, Singhvi, Aditi, Tripathi, Nidhi, Henzlova, Milena J.
Format: Article
Language:English
Subjects:
Aged
Cardiology
Coronary Angiography
Coronary Artery Disease - diagnostic imaging
Coronary Artery Disease - epidemiology
Ejection fraction
Female
Humans
Imaging
Incidence
instrumentation
Liver
Liver Failure - complications
Liver Failure - diagnostic imaging
Liver Failure - surgery
Liver Transplantation
Liver transplants
Male
Medical imaging
Medicine
Medicine & Public Health
Middle Aged
Myocardial Perfusion Imaging
Nuclear Medicine
Original Article
Patient Selection
Patients
Radiology
Retrospective Studies
sarcoid heart disease
Tomography, Emission-Computed, Single-Photon
Transplant rejection
Transplants & implants
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The optimal cardiovascular evaluation prior to liver transplantation remains controversial and includes stress echocardiography, stress MPI, cardiac CTA, and coronary angiography. This study summarizes our experience of the past decade using SPECT MPI in patients with end-stage liver disease, including patient characteristics, stress testing protocols, test results, the need for repeat testing, and downstream testing. All patients who underwent a clinically indicated stress SPECT MPI study as part of their pre-liver transplant evaluation from 2004 to 2014 were reviewed from the Nuclear Cardiology database. Results of perfusion imaging, repeat testing, subsequent angiography, and need for revascularization were reviewed. A total of 2500 patients were referred for SPECT MPI, of those 111 had known CAD and 271 underwent more than one MPI study. Compared to other patients undergoing stress MPI, pre-liver transplant patients were younger, had fewer cardiac risk factors and lower prevalence of prior cardiac history, and used pharmacologic stress more often. During the study decade, patient age increased, prevalence of hypertension increased and smoking decreased, prevalence of known CAD increased, and the number of abnormal studies decreased. Abnormal perfusion results were present in 7.8% of pre-liver transplant patients compared to 34.3% of all other patients. In a multivariate model, age and lower ejection fraction were associated with an abnormal MPI result. Of the 64 patients who underwent subsequent invasive or non-invasive coronary angiography after an abnormal MPI, obstructive CAD was diagnosed in 25 patients (1.0%), non-obstructive CAD was diagnosed in 23 patients (0.9%), and normal coronaries found in 16 patients (0.6%); a total of 18 (0.7%) of these underwent coronary revascularization. The average time to repeat testing was 27.2 ± 17.9 months. In a multivariate model, younger age and exercise stress were associated with repeat testing. In only 17 patients out of 271 with a normal initial perfusion, the repeat study became abnormal. The use of stress-first imaging was successful in 80% of patients with a reduction in Tc-99m dose from 39.1 to 18.3 mCi. Abnormal SPECT MPI results in candidates for liver transplantation are infrequent compared to non-liver transplant patients and the incidence of obstructive CAD on subsequent angiography even less. Repeat testing in those on the transplant waiting list after initial normal test results appears to be of l
ISSN:1071-3581
1532-6551
DOI:10.1007/s12350-018-1388-3